Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The 50 most-cited articles on Lisfranc injuries: A bibliometric analysis.

Created on 05 Sep 2026

Authors

Lolita Micicoi, Wolfram Grün, Barbara Piclet-Legre, Enrico Pozzessere, Cesar de Cesar Netto, Jean-François Gonzalez

Published in

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons. Sep 02, 2026. Epub Sep 02, 2026.

Abstract

Lisfranc injuries are bony and ligamentous disruptions of the tarsometatarsal joint complex associated with significant morbidity, and several aspects of their management remain controversial. To our knowledge, no citation analysis dedicated to Lisfranc injuries has been published.
The Web of Science Core Collection was searched on May 1, 2026. After document-type and language filters, articles were sorted by citation count, and two reviewers screened the top 100 records to identify the 50 most-cited articles primarily focused on Lisfranc injuries.
The 50 articles accumulated 4911 citations (mean 98.2 ± 51.5; range 49-274) and were published between 1973 and 2020. Foot & Ankle International was the most prolific journal (28%), and the United States contributed 64% of articles. Eighty percent were Level IV-V evidence; only 6% were Level I-II.
Higher-quality comparative trials are needed to address persistent controversies, particularly regarding optimal surgical management.
Level V (bibliometric analysis).

PMID:
42697792
Bibliographic data and abstract were imported from PubMed on 05 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement